Cargando…
A successful antenatal outcome in a patient with refractory Takayasu’s arteritis treated with tocilizumab throughout pregnancy—a case report
Takayasu’s arteritis (TA) is a rare form of large-vessel vasculitis for which tocilizumab (TCZ) may be administered in resistant or refractory disease. Current British Society of Rheumatology advice is to stop TCZ 3-months pre-conception. We report the case of a 33-year-old woman with extensive TA t...
Autores principales: | Khan, Behram, David, Trixy, Sussman, Jon, Simcox, Louise, Tower, Clare, Soh, Calvin, Bruce, Ian N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228108/ https://www.ncbi.nlm.nih.gov/pubmed/37260724 http://dx.doi.org/10.1093/omcr/omad046 |
Ejemplares similares
-
Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022) -
Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020) -
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
por: Prieto-Peña, Diana, et al.
Publicado: (2021) -
FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014) -
Intracranial Involvement in Takayasu’s Arteritis
por: Johnson, Andrea, et al.
Publicado: (2021)